Table 2 Treatments characteristics
From: In vivo validation of the adequacy calculator for continuous renal replacement therapies
Parameter | Value |
|---|---|
No. of treatments | 106 |
Total no. of examined K CALC /K DEL (ml min-1) | 179 (106 T0; 73 T18) |
   CVVHpost | 38 (19 T0; 19 T18) |
   CVVHpre | 30 (23 T0; 7 T18) |
   CVVHD | 29 (23 T0; 6 T18) |
   CVVHDF | 82 (42 T0; 42 T18) |
Total prescribed KCALC (ml min-1) | 48.6 ± 24; 18–100 |
   CVVHpost | 35.6 ± 16; 16–66 |
   CVVHpre | 48.8 ± 19; 15–83 |
   CVVHD | 56.2 ± 28; 20–100 |
   CVVHDFa | 52.2 ± 24; 23–100 |
Total prescribed net UF (ml h-1) | 250 ± 100; 0–500 |
Treatment hours per day | 20 ± 3; 8.5–24 |
Treatment hours per run | 17 ± 6; 5–24 |
Downtime (hours) | 3 ± 2 |